0001104659-21-099627.txt : 20210803
0001104659-21-099627.hdr.sgml : 20210803
20210803185007
ACCESSION NUMBER: 0001104659-21-099627
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210731
FILED AS OF DATE: 20210803
DATE AS OF CHANGE: 20210803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Greenspan Ira Scott
CENTRAL INDEX KEY: 0001449211
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39788
FILM NUMBER: 211141598
MAIL ADDRESS:
STREET 1: 888 SEVENTH AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Scopus BioPharma Inc.
CENTRAL INDEX KEY: 0001772028
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821248020
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 420 LEXINGTON AVENUE, SUITE 300
CITY: NEW YORK
STATE: NY
ZIP: 10170
BUSINESS PHONE: (212) 479-2513
MAIL ADDRESS:
STREET 1: 420 LEXINGTON AVENUE, SUITE 300
CITY: NEW YORK
STATE: NY
ZIP: 10170
FORMER COMPANY:
FORMER CONFORMED NAME: Scopus Biopharma Inc.
DATE OF NAME CHANGE: 20190327
4
1
tm2123824d1_4.xml
OWNERSHIP DOCUMENT
X0306
4
2021-07-31
0
0001772028
Scopus BioPharma Inc.
SCPS
0001449211
Greenspan Ira Scott
C/O SCOPUS BIOPHARMA INC.
420 LEXINGTON AVENUE, SUITE 300
NEW YORK
NY
10170
1
1
1
0
Executive Committee Chairman
W Warrants
4.00
2021-07-31
4
J
0
1068016
A
2021-10-01
2026-09-30
B Unit
1068016
1068016
I
SCPS/Strategic Capital Partners LLC
Represents W Warrants held by SCPS/Strategic Capital Partners LLC, of which Mr. Greenspan is a co-manager. Accordingly, he is deemed to have shared voting and dispositive power over the securities held by such entity. Mr. Greenspan disclaims beneficial ownership of such securities, except to the extent of his proportionate pecuniary interest therein.
Each W Warrant is exercisable for one B Unit. Starting on April 1, 2022, each B Unit can be separated into one share of common stock and one Z Warrant. Each Z Warrant is exercisable for one share of common stock with an exercise price of $5.00 per share. The Z Warrant will become exercisable on July 1, 2022 and will expire on June 30, 2027.
/s/ Ira Scott Greenspan
2021-08-03